Skip to main content

Applied Markets Watch: Life Tech RapidFinder Equine ID; EnviroLogix DNAble Salmonella Test Kit


Life Technologies said this week that it has developed the RapidFinder Equine ID kit in collaboration with the Instituto de Medicina Genómica.

The new kit detects the presence of equine DNA extracted from meat samples, and is optimized for use in all Applied Biosystems real-time PCR instruments.

The kit comprises all reagents necessary for 48 reactions, and offers a detection limit of 0.01 percent (w/w) in fresh meat. The kit includes a positive control consisting of 0.1 percent horse DNA. It also includes a quantification kit with a limit of 0.05 percent (w/w) and includes the standard for quantification.

RapidFinder Equine ID is available immediately in Europe, Middle East, and Africa via Life Tech's distributors according to local regulatory requirements.

EnviroLogix has introduced the DNAble Salmonella Rapid Screening Kit for live poultry production.

DNAble is a rapid, highly specific isothermal nucleic acid amplification technology that can amplify DNA targets with single-base resolution a billion-fold in 5 to 10 minutes at a constant temperature. A nicking enzyme and a strand-displacing polymerase are used to generate small pieces of DNA that feed a DNA extension reaction that consists of alternating cycles of nicking and extension processes leading to exponential amplification.

According to the company, DNAble is faster than current PCR methods, and offers at least comparable sensitivity and specificity. Unlike PCR, DNAble shows little inhibitory effect from a crude extraction or exogenous DNA. As a result, it allows for highly sensitive detection with minimal to no sample preparation, the company said.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.